Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DocMorris AGXSWX:DOCM +0.99%65 Cash-to-Debt is 0.74 as of Jun. 2025, which is 51% above its 10-year median of 0.49. GuruFocus rates XSWX:DOCM with a GF Score™ of 65/100 and a GF Value™ of CHF10.61 (Fairly Valued). The stock has 8 warning signs investors should review. Among 668 Healthcare Providers & Services companies, DocMorris AG ranks worse than 51.5% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. DocMorris AG's cash to debt ratio for the quarter that ended in Jun. 2025 was 0.74.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, DocMorris AGcouldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2025.
The historical rank and industry rank for DocMorris AG's Cash-to-Debt or its related term are showing as below:
XSWX:DOCM'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.29 Med: 0.49 Max: 26.07
Current: 0.74
During the past 13 years, DocMorris AG's highest Cash to Debt Ratio was 26.07. The lowest was 0.29. And the median was 0.49.
XSWX:DOCM's Cash-to-Debt is ranked worse than 51.5% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 0.78
vs XSWX:DOCM: 0.74
DocMorris AG (XSWX:DOCM) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
DocMorris AG Cash-to-Debt Related Terms
DocMorris AG Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for DocMorris AG's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Pharmaceutical Retailers subindustry, DocMorris AG's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG Cash-to-Debt vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where DocMorris AG's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG (XSWX:DOCM) has a Cash-to-Debt of 0.74 as of Jun. 2025. This is 51% above median its historical median of 0.49. Over the past decade, DocMorris AG's Cash-to-Debt has ranged from 0.29 to 26.07. According to the industry distribution chart, DocMorris AG ranks #344 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 51.5%.
Is DocMorris AG's Cash-to-Debt too high?
DocMorris AG's current Cash-to-Debt of 0.74 is 51% above median its 10-year median of 0.49. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 26.07. The Healthcare Providers & Services industry median Cash-to-Debt is 0.78. DocMorris AG's value of 0.74 is 5.1% below this industry median. Based on the distribution chart, DocMorris AG ranks #344 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Cash-to-Debt compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #344 out of 668 companies for Cash-to-Debt. This places DocMorris AG in the lower half of its industry. The industry median Cash-to-Debt is 0.78. DocMorris AG's value of 0.74 is 5.1% below this benchmark. Historically, DocMorris AG's own Cash-to-Debt has ranged from 0.29 to 26.07 over the past decade. While the company's 10-year median is 0.49 vs. the industry median of 0.78, DocMorris AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.78, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocMorris AG's current Cash-to-Debt of 0.74 is 5.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocMorris AG's current Cash-to-Debt is 0.74, which is 51% above median its own 10-year median of 0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Fairly Valued. The stock's GF Value™ is CHF10.61, compared to a current price of CHF10.16 — trading 4.2% below its estimated fair value. The current Cash-to-Debt is 0.74, which is 51% above median its 10-year median of 0.49 and 5.1% below the Healthcare Providers & Services industry median of 0.78. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current Cash-to-Debt is 0.74 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF10.16 is trading 4.2% below its estimated GF Value™ of CHF10.61.
GuruFocus considers DocMorris AG to be Fairly Valued.
Key valuation signals for XSWX:DOCM:
Cash-to-Debt: 0.74 (51% above median its 10-year median of 0.49)
GF Value™: CHF10.61 vs. price of CHF10.16 (4.2% below fair value)
Industry Position: 5.1% below the Healthcare Providers & Services median (#344 of 668)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score
Get the complete analysis for XSWX:DOCM
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 
